Human cytotoxic T cell responses to vaccinia virus vaccination
- PMID: 2033393
- DOI: 10.1099/0022-1317-72-5-1183
Human cytotoxic T cell responses to vaccinia virus vaccination
Abstract
Recombinant vaccinia viruses have been proposed as live virus vectors in man to generate both specific humoral and cellular immune responses. The generation of such responses following revaccination was followed in five normal volunteers. All five showed elevated (35- to 6500-fold) vaccinia virus-specific IgG by 14 days post-vaccination, following uncomplicated vaccination by dermal scarification. Four of the five had elevated total serum immunoglobulins with increased spontaneous and pokeweed mitogen-induced immunoglobulin production. Major histocompatibility complex class I-restricted vaccinia virus-specific cytotoxic T lymphocytes (CTLs) were not detected either directly, from peripheral blood mononuclear cells, or following secondary in vitro stimulation, even by limiting dilution analysis. These studies would suggest that vaccination with recombinant vaccinia viruses may provide an insufficient stimulus to the generation of CTLs in vivo.
Similar articles
-
Long-term humoral and cellular immunity induced by a single immunization with replication-defective adenovirus recombinant vector.Eur J Immunol. 1995 Dec;25(12):3467-73. doi: 10.1002/eji.1830251239. Eur J Immunol. 1995. PMID: 8566039
-
Immunization with recombinant modified vaccinia Ankara (rMVA) constructs encoding the HA or NP gene protects ponies from equine influenza virus challenge.Vaccine. 2006 Feb 20;24(8):1180-90. doi: 10.1016/j.vaccine.2005.08.091. Epub 2005 Sep 12. Vaccine. 2006. PMID: 16194586
-
The immune response to vaccinia virus is significantly reduced after scarification with TK- recombinants as compared to wild-type virus.Acta Virol. 2000 Jun-Aug;44(3):151-6. Acta Virol. 2000. PMID: 11155357
-
Vaccinia virus expression vectors.J Gen Virol. 1986 Oct;67 ( Pt 10):2067-82. doi: 10.1099/0022-1317-67-10-2067. J Gen Virol. 1986. PMID: 3531399 Review. No abstract available.
-
Roles of vaccinia virus in the development of new vaccines.Vaccine. 1988 Apr;6(2):161-3. doi: 10.1016/s0264-410x(88)80021-5. Vaccine. 1988. PMID: 3291453 Review.
Cited by
-
Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers.Proc Natl Acad Sci U S A. 1997 Feb 18;94(4):1396-401. doi: 10.1073/pnas.94.4.1396. Proc Natl Acad Sci U S A. 1997. PMID: 9037064 Free PMC article.
-
Vaccinia virus-specific CD8+ cytotoxic T lymphocytes in humans.J Virol. 1993 Mar;67(3):1538-44. doi: 10.1128/JVI.67.3.1538-1544.1993. J Virol. 1993. PMID: 8437229 Free PMC article.
-
Vaccinia virus-specific human CD4+ cytotoxic T-lymphocyte clones.J Virol. 1992 Apr;66(4):2274-80. doi: 10.1128/JVI.66.4.2274-2280.1992. J Virol. 1992. PMID: 1548761 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical